NanoRepro AG (NN6) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.055x

Based on the latest financial reports, NanoRepro AG (NN6) has a cash flow conversion efficiency ratio of 0.055x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.05 Million ≈ $2.40 Million USD) by net assets (€37.30 Million ≈ $43.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NanoRepro AG (NN6) defensive interval to measure how many days the company can operate on defensive assets alone.

NanoRepro AG - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how NanoRepro AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NanoRepro AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NanoRepro AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Amanet Management & Systems Ltd TA:AMAN	0.066x
Blackrock World Mining Trust Plc LSE:BRWM	0.012x
FibroBiologics, Inc. Common Stock NASDAQ:FBLG	-31.776x
Quest Resource Holding Corp NASDAQ:QRHC	0.005x
KONG SUN (BL25000) F:KOJ5	N/A
HANBIT SOFT Inc KQ:047080	0.030x
MegaMD Co. Ltd KQ:133750	-0.005x
Pulsenmore Ltd. Ordinary Shares NASDAQ:PLSM	-0.344x

Annual Cash Flow Conversion Efficiency for NanoRepro AG (2013–2024)

The table below shows the annual cash flow conversion efficiency of NanoRepro AG from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see NanoRepro AG market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€38.14 Million ≈ $44.59 Million	€9.86 Million ≈ $11.53 Million	0.259x	+201.70%
2023-12-31	€40.38 Million ≈ $47.20 Million	€-10.26 Million ≈ $-12.00 Million	-0.254x	-191.73%
2022-12-31	€47.43 Million ≈ $55.45 Million	€13.14 Million ≈ $15.37 Million	0.277x	+95.60%
2021-12-31	€57.61 Million ≈ $67.35 Million	€8.16 Million ≈ $9.54 Million	0.142x	+200.82%
2020-12-31	€7.99 Million ≈ $9.34 Million	€-1.12 Million ≈ $-1.31 Million	-0.141x	-1.63%
2019-12-31	€4.43 Million ≈ $5.18 Million	€-612.40K ≈ $-715.96K	-0.138x	-201.53%
2018-12-31	€5.62 Million ≈ $6.57 Million	€-257.60K ≈ $-301.16K	-0.046x	+84.68%
2017-12-31	€3.82 Million ≈ $4.47 Million	€-1.14 Million ≈ $-1.34 Million	-0.299x	-18.04%
2016-12-31	€3.03 Million ≈ $3.55 Million	€-769.70K ≈ $-899.86K	-0.254x	+38.28%
2015-12-31	€2.27 Million ≈ $2.66 Million	€-934.60K ≈ $-1.09 Million	-0.411x	-43.01%
2014-12-31	€1.91 Million ≈ $2.23 Million	€-548.00K ≈ $-640.67K	-0.287x	+39.65%
2013-12-31	€1.64 Million ≈ $1.92 Million	€-783.00K ≈ $-915.41K	-0.476x	--

About NanoRepro AG

XETRA:NN6 Germany Diagnostics & Research

Market Cap

$29.79 Million

€25.48 Million EUR

Market Cap Rank

#24764 Global

#2141 in Germany

Share Price

€2.02

Change (1 day)

+1.00%

52-Week Range

€1.38 - €2.02

All Time High

€17.14